CONMED Corp.

History

Year	Detail
1970	CONMED Corp. was established under the laws of the State of New York.
1997	CONMED Corp. acquired the business division and certain assets of Linvatec Corp. from Bristol-Myers Squibb Co. for a cash of $370.0 million.
2004	CONMED Corp. acquired a larger share of the gastroenterology and pulmonary business from C.R. Bard to expand its presence in the general surgery market.
2011	CONMED Corp. partnered with the Musculoskeletal Transplant Foundation (MTF), one of the largest tissue banks for sports medicine applications. Under this partnership, CONMED's subsidiary, CONMED Linvatec, will serve as a marketing representative for MTF's sports medicine allograft tissues globally.
2016	CONMED Corp. acquired a privately-held SurgiQuest, Inc. (SurgiQuest), which will now become a part of the CONMED Advanced Surgical business.
2019	CONMED Corp. acquired Buffalo Filter, one of the leading surgical smoke evacuation and filter technology providers, to cement its spot as a leader in surgical smoke management solutions.
2022	CONMED Corp. acquired In2Bones Global, Inc. (In2Bones) to enhance its solutions for the treatment of disorders and injuries in the upper and lower extremities.